These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 18958546)

  • 1. The effect of tacrolimus (FK-506) on Japanese patients with refractory Crohn's disease.
    Tamaki H; Nakase H; Matsuura M; Inoue S; Mikami S; Ueno S; Uza N; Kitamura H; Kasahara K; Chiba T
    J Gastroenterol; 2008; 43(10):774-9. PubMed ID: 18958546
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tacrolimus is safe and effective in patients with severe steroid-refractory or steroid-dependent inflammatory bowel disease--a long-term follow-up.
    Baumgart DC; Pintoffl JP; Sturm A; Wiedenmann B; Dignass AU
    Am J Gastroenterol; 2006 May; 101(5):1048-56. PubMed ID: 16573777
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Medium-term results of oral tacrolimus treatment in refractory inflammatory bowel disease.
    Ng SC; Arebi N; Kamm MA
    Inflamm Bowel Dis; 2007 Feb; 13(2):129-34. PubMed ID: 17206694
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term oral tacrolimus therapy in refractory to infliximab fistulizing Crohn's disease: a pilot study.
    González-Lama Y; Abreu L; Vera MI; Pastrana M; Tabernero S; Revilla J; Durán JG; Escartin P
    Inflamm Bowel Dis; 2005 Jan; 11(1):8-15. PubMed ID: 15674108
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preliminary report on the use of oral tacrolimus (FK506) in the treatment of complicated proximal small bowel and fistulizing Crohn's disease.
    Sandborn WJ
    Am J Gastroenterol; 1997 May; 92(5):876-9. PubMed ID: 9149205
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tacrolimus salvage in anti-tumor necrosis factor antibody treatment-refractory Crohn's disease.
    Gerich ME; Pardi DS; Bruining DH; Kammer PP; Becker BD; Tremaine WT
    Inflamm Bowel Dis; 2013 May; 19(6):1107-11. PubMed ID: 23518805
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Steroid-unresponsive acute attacks of inflammatory bowel disease: immunomodulation by tacrolimus (FK506).
    Fellermann K; Ludwig D; Stahl M; David-Walek T; Stange EF
    Am J Gastroenterol; 1998 Oct; 93(10):1860-6. PubMed ID: 9772045
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combining infliximab with methotrexate for the induction and maintenance of remission in refractory Crohn's disease: a controlled pilot study.
    Schröder O; Blumenstein I; Stein J
    Eur J Gastroenterol Hepatol; 2006 Jan; 18(1):11-6. PubMed ID: 16357613
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Methotrexate for induction of remission in refractory Crohn's disease.
    McDonald JW; Tsoulis DJ; Macdonald JK; Feagan BG
    Cochrane Database Syst Rev; 2012 Dec; 12():CD003459. PubMed ID: 23235598
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral tacrolimus (FK 506) in Crohn's disease complicated by fistulae of the perineum.
    Ierardi E; Principi M; Rendina M; Francavilla R; Ingrosso M; Pisani A; Amoruso A; Panella C; Francavilla A
    J Clin Gastroenterol; 2000 Mar; 30(2):200-2. PubMed ID: 10730928
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Azathioprine or 6-mercaptopurine for induction of remission in Crohn's disease.
    Chande N; Townsend CM; Parker CE; MacDonald JK
    Cochrane Database Syst Rev; 2016 Oct; 10(10):CD000545. PubMed ID: 27783843
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rescue therapy with tacrolimus is effective in patients with severe and refractory inflammatory bowel disease.
    Baumgart DC; Wiedenmann B; Dignass AU
    Aliment Pharmacol Ther; 2003 May; 17(10):1273-81. PubMed ID: 12755840
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tacrolimus for Crohn's disease.
    Ruddock B
    Issues Emerg Health Technol; 2006 Sep; (88):1-4. PubMed ID: 16981314
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Azathioprine or 6-mercaptopurine for maintenance of remission in Crohn's disease.
    Chande N; Patton PH; Tsoulis DJ; Thomas BS; MacDonald JK
    Cochrane Database Syst Rev; 2015 Oct; 2015(10):CD000067. PubMed ID: 26517527
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combination therapy with oral tacrolimus (FK506) and azathioprine or 6-mercaptopurine for treatment-refractory Crohn's disease perianal fistulae.
    Lowry PW; Weaver AL; Tremaine WJ; Sandborn WJ
    Inflamm Bowel Dis; 1999 Nov; 5(4):239-45. PubMed ID: 10579116
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systematic review: the role of tacrolimus in the management of Crohn's disease.
    McSharry K; Dalzell AM; Leiper K; El-Matary W
    Aliment Pharmacol Ther; 2011 Dec; 34(11-12):1282-94. PubMed ID: 21999607
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oral tacrolimus for the treatment of refractory inflammatory bowel disease in the biologic era.
    Thin LW; Murray K; Lawrance IC
    Inflamm Bowel Dis; 2013 Jun; 19(7):1490-8. PubMed ID: 23615528
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transcending conventional therapies: the role of biologic and other novel therapies.
    Sandborn WJ
    Inflamm Bowel Dis; 2001 May; 7 Suppl 1():S9-16. PubMed ID: 11380043
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Azathioprine or 6-mercaptopurine for induction of remission in Crohn's disease.
    Chande N; Tsoulis DJ; MacDonald JK
    Cochrane Database Syst Rev; 2013 Apr; (4):CD000545. PubMed ID: 23633304
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral tacrolimus long-term therapy in patients with Crohn's disease and steroid resistance.
    Ierardi E; Principi M; Francavilla R; Pisani A; Rendina M; Ingrosso M; Guglielmi FW; Panella C; Francavilla A
    Aliment Pharmacol Ther; 2001 Mar; 15(3):371-7. PubMed ID: 11207512
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.